US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

38.19

-0.3100-0.81%

Volume:632.57K

Turnover:24.50M

Market Cap:5.13B

PE:-10.97

High:40.07

Open:38.50

Low:38.10

Close:38.50

52wk High:49.70

52wk Low:8.70

Shares:134.37M

Float Shares:131.11M

Volume Ratio:0.58

T/O Rate:0.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:5.59

PE(LYR):-18.54

Loading ...

Overview Company News Filings

Definium Therapeutics Grants 88,900 Inducement Stock Options to New Hires

Definium Therapeutics, Inc. put volume heavy and directionally bearish

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Definium Therapeutics (DFTX) and IDEAYA Biosciences (IDYA)

Definium Therapeutics (DFTX) Gets a Buy from Stifel Nicolaus

Definium Therapeutics to Present at TD Cowen Novel Mechanisms in Neuropsychiatry Summit

Definium Therapeutics Posts Strong Phase 3 GAD Data for DT120

Definium Therapeutics Issues Inducement Stock Options to New Hires

Definium Therapeutics Initiated at Buy by B of a Securities

Definium Therapeutics initiated with a Buy at BofA

Definium Therapeutics Issues Inducement Stock Options for 32,900 Shares to New Hires

Definium Therapeutics price target raised to $66 from $57 at RBC Capital

Definium Therapeutics Price Target Raised to $55.00/Share from $50.00 by Maxim Group

Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Sutro Biopharma (STRO)

Definium Therapeutics Publishes Corporate Presentation Outlining DT120 ODT Clinical Development Pipeline in Mental Health Indications

Definium Therapeutics' DT120 Data Boosts Confidence in Future Trials, RBC Capital Markets Says

MT Newswires Live

RBC Adjusts PT on Definium Therapeutics to $66 From $57, Keeps Outperform Speculative Risk Rating

MT Newswires Live

U.S. Research Roundup-Airbnb, Five Below, Silgan Holdings

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live

Definium Therapeutics Price Target Raised to $66.00/Share from $50.00 by Needham

U.S. Stocks on the MOVE-Sutro Biopharma, Humacyte

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/DFTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":38.19,"timestamp":1788369904581,"preClose":38.5,"halted":0,"volume":632569,"delay":0,"changeRate":-0.00805194805194811,"floatShares":131114280,"shares":134366950,"eps":-3.482311,"marketStatus":"Trading","change":-0.31,"latestTime":"09-02 13:25:08 EDT","open":38.5,"high":40.065,"low":38.1,"amount":24496323.08466,"amplitude":0.051039,"askPrice":38.19,"askSize":533,"bidPrice":38.13,"bidSize":147,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":38.5,"preHourTrading":{"tag":"盘前","latestPrice":38.3,"preClose":38.5,"latestTime":"09:27 EDT","volume":6540,"amount":246819.8616,"timestamp":1788355679328,"change":-0.2,"changeRate":-0.005195,"amplitude":0.037922},"postHourTrading":{"tag":"盘后","latestPrice":38.6,"preClose":38.5,"latestTime":"19:58 EDT","volume":24860,"amount":958344.1953,"timestamp":1788307117321,"change":0.1,"changeRate":0.002597,"amplitude":0.01974},"volumeRatio":0.575294,"impliedVol":1.0401,"impliedVolPercentile":0.6329},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":131114280,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":0.575294,"shares":134366950,"dividePrice":0,"high":40.065,"amplitude":0.051039,"preClose":38.5,"low":38.1,"week52Low":8.7,"pbRate":"5.59","week52High":49.7,"institutionHeld":0,"latestPrice":38.19,"committee":-0.567647,"eps":-3.482311,"divideRate":0,"volume":632569,"delay":0,"ttmEps":-3.482311,"open":38.5,"prevYearClose":13.39,"prevWeekClose":40.98,"prevMonthClose":39.72,"prevQuarterClose":47.04,"fiveDayClose":43.77,"twentyDayClose":44.39,"sixtyDayClose":23.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-09-01","current":-11.055876,"percent":0.307692,"low":-27.074722,"twenty":-17.384314,"median":-11.106728,"eighty":-9.894411,"high":-8.802064,"avg":-13.907193,"sd":5.5199,"marketCap":5337055254},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-01","current":-15.085589,"twenty":-17.384314,"median":-11.106728,"eighty":-9.894411,"marketCap":5337055254}],"updateTime":1788341670804},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664178888","title":"Definium Therapeutics Grants 88,900 Inducement Stock Options to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2664178888","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664178888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:01","pubTimestamp":1788206496,"startTime":"0","endTime":"0","summary":"Definium Therapeutics grants 88,900 inducement stock options to new hiresDefinium Therapeutics issued inducement stock options for 88,900 common shares to three newly hired non-executive employees.Gra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL1P0HbT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663002865","title":"Definium Therapeutics, Inc. put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002865","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002865?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:15","pubTimestamp":1788189307,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Definium Therapeutics (DFTX), Inc. with 2,903 puts trading, or 6x expected. Most active are Oct-26 37 puts and Oct-26 50 call...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-inc-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-inc-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663700958","title":"Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Definium Therapeutics (DFTX) and IDEAYA Biosciences (IDYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663700958","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663700958?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:50","pubTimestamp":1788184220,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vor Biopharma (VOR), Definium Therapeutics (DFTX) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vor-biopharma-vor-definium-therapeutics-dftx-and-ideaya-biosciences-idya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vor-biopharma-vor-definium-therapeutics-dftx-and-ideaya-biosciences-idya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","BK4581","XBI","VOR","IDYA","BK4137","DFTX","LU0029874061.USD","XLV","LU0128526141.USD","BK4139","BK4585","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663070428","title":"Definium Therapeutics (DFTX) Gets a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2663070428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663070428?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:36","pubTimestamp":1788176219,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Definium Therapeutics today and set a price target of $60.00. Matteis covers the He...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/definium-therapeutics-dftx-gets-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/definium-therapeutics-dftx-gets-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662571336","title":"Definium Therapeutics to Present at TD Cowen Novel Mechanisms in Neuropsychiatry Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2662571336","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662571336?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:05","pubTimestamp":1787742344,"startTime":"0","endTime":"0","summary":"Definium Therapeutics to present at TD Cowen Novel Mechanisms in Neuropsychiatry SummitDefinium Therapeutics schedules a virtual fireside chat on Tuesday, Sept. 1, 2026 at 1:00 p.m. ET.Discussion to c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLnMHt6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","DFTX","BK4007","MNSH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492449","title":"Definium Therapeutics Posts Strong Phase 3 GAD Data for DT120","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492449","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492449?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:40","pubTimestamp":1787085632,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) has issued an announcement. Definium Therapeutics reported positive topline Phase 3 results from its Voyage study...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-posts-strong-phase-3-gad-data-for-dt120?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-posts-strong-phase-3-gad-data-for-dt120?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492414","title":"Definium Therapeutics Issues Inducement Stock Options to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492414","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492414?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:39","pubTimestamp":1787085575,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) just unveiled an announcement. Definium Therapeutics has granted stock options to two newly hired non‑executive e...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-inducement-stock-options-to-new-hires-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-inducement-stock-options-to-new-hires-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660846586","title":"Definium Therapeutics Initiated at Buy by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2660846586","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660846586?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:17","pubTimestamp":1787044620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660550624","title":"Definium Therapeutics initiated with a Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2660550624","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660550624?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:55","pubTimestamp":1787018108,"startTime":"0","endTime":"0","summary":"BofA analyst Tazeen Ahmad initiated coverage of Definium Therapeutics (DFTX) with a Buy rating and $75 price target The company’s lead asset, DT120...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-initiated-with-a-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-initiated-with-a-buy-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660643426","title":"Definium Therapeutics Issues Inducement Stock Options for 32,900 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2660643426","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660643426?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:01","pubTimestamp":1786996877,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement stock options for 32,900 shares to new hiresDefinium Therapeutics issued inducement stock options covering 32,900 common shares to two newly hired non-executive","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL47wSLg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660488352","title":"Definium Therapeutics price target raised to $66 from $57 at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2660488352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660488352?lang=en_us&edition=fundamental","pubTime":"2026-08-17 15:41","pubTimestamp":1786952513,"startTime":"0","endTime":"0","summary":"RBC Capital raised the firm’s price target on Definium Therapeutics (DFTX) to $66 from $57 and keeps an Outperform rating on the shares. Following ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-66-from-57-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-66-from-57-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129989","title":"Definium Therapeutics Price Target Raised to $55.00/Share from $50.00 by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129989?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:21","pubTimestamp":1786738860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123102","title":"Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Sutro Biopharma (STRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659123102?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:00","pubTimestamp":1786726822,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Su...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definium-therapeutics-dftx-ionis-pharmaceuticals-ions-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definium-therapeutics-dftx-ionis-pharmaceuticals-ions-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","LU0029874061.USD","HCSG","BK4007","XLV","BK4585","XBI","BK4139","LU0128526141.USD","IONS","BK4588","DFTX","BK4137","STRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167311","title":"Definium Therapeutics Publishes Corporate Presentation Outlining DT120 ODT Clinical Development Pipeline in Mental Health Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167311","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167311?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:20","pubTimestamp":1786652405,"startTime":"0","endTime":"0","summary":"Definium Therapeutics publishes corporate presentation outlining DT120 ODT clinical development pipeline in mental health indicationsDefinium outlined a late-stage program for DT120 ODT (lysergide) ta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2pQv6j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659516574","title":"Definium Therapeutics' DT120 Data Boosts Confidence in Future Trials, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2659516574","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659516574?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:44","pubTimestamp":1786635856,"startTime":"0","endTime":"0","summary":"Definium Therapeutics' (DFTX) phase 3 data for DT120 in generalized anxiety disorder looked better than the stock's muted reaction suggests, with the results increasing confidence in future studies an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LU0128525929.USD","LU0708994859.HKD","LU0029864427.USD","BK4207","LU1267930573.SGD","DFTX","GSIB","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659415539","title":"RBC Adjusts PT on Definium Therapeutics to $66 From $57, Keeps Outperform Speculative Risk Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2659415539","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659415539?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:40","pubTimestamp":1786617635,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) has an average rating of buy and mean price target of $65.69, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659139535","title":"U.S. Research Roundup-Airbnb, Five Below, Silgan Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2659139535","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659139535?lang=en_us&edition=fundamental","pubTime":"2026-08-13 14:48","pubTimestamp":1786603733,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan HoldingsAug 13 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Airbnb, Fi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4N44A0G6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSCO","CC","AIZ","ABNB","AMWL","CHRD","GASZ","AMTM","ARXS","AKAM","EAT","PKB","AMRZ","ATO","BESF","LNG","ANRO","ARMK","DFTX","ACM","CRGY","DVN","PXI","AX","CBRS","SPRX","CRWV","AOSL","MLPI","CORD","BBY","BGS","AHR","CAH","COHX","CYTK","APGE","APA","ALGM","CSV","COHR","COHC","BTGO","COHH","CRWG","AADX","ACH","AIQ","ANDG","ALL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907385","title":"Sector Update: Healthcare Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907385","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907385?lang=en_us&edition=fundamental","pubTime":"2026-08-13 03:58","pubTimestamp":1786564721,"startTime":"0","endTime":"0","summary":"Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and the State Street Health Care Select Sector SPDR ETF  adding 0.3%.The iShares Biotechnology ETF  rose 0.5%.In corporate news, Merck  shares rose 2.4% after Daiwa upgraded the stock to outperform from neutral and raised its price target to $143 per share from $120.Cencora  said that certain Walgreens volume that was being serviced by the company, separate from the prime vendor agreement, has started moving outside the company from July 1. Meanwhile, Cencora said its prime vendor agreement remains unchanged and accounts for the majority of its business with Walgreens. Cencora shares fell past 5%.Legend Biotech  could see pressures from competition and recent leadership change, potentially weighing on Carvykti myeloma therapy strategy, Oppenheimer said. It downgraded Legend to perform from outperform. Shares fell 5.2%.Definium Therapeutics  shares rose 5% after the firm said its phase 3 trial","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2361045086.USD","LU2433249047.HKD","LU0477156953.USD","IE0009355771.USD","RXL","SG9999013999.USD","IYH","LU1291159041.SGD","LU0106261372.USD","LU1162221912.USD","LU1430594728.SGD","LU0320765646.SGD","LU0320765489.SGD","LU2125909593.SGD","LU0965509010.AUD","IE00BJT1NW94.SGD","PAWZ","LU1066053197.SGD","LU1941712264.USD","LU1941712348.USD","LU2360032135.SGD","COR","LU1037948897.HKD","LU1989772840.SGD","DFTX","BK4550","LU0208291251.USD","BMED","IE00BLSP4452.SGD","LU2023250843.SGD","LABU","LU1699723380.USD","LU0965508806.USD","BK4084","LU2461242641.AUD","SG9999004303.SGD","IE0002141913.USD","LU0648001328.SGD","SG9999001176.SGD","SG9999014559.SGD","SG9999002232.USD","LU0122379950.USD","BK4175","LU0859254822.USD","HRTS","FTXH","BK4529","LU2468319806.SGD","LU1201861249.SGD","IE00B1BXHZ80.USD","LU2106854487.HKD","LU2237957902.USD","CANC","LU0942090050.USD","LU0861579265.USD","IXJ","LU1983299246.USD","LU0868494708.USD","LU0203345920.USD","PPH","LU1974910355.USD","LU1814569148.SGD","LU1093756325.SGD","LU0985320562.USD","LU1929549753.HKD","LU2112291526.USD","IE00B4R5TH58.HKD","LU1119994496.HKD","BK4581","BK4588","BK4139","XBI","MRK","LU0689626769.HKD","FHLC","MEMS","BK4516","LU0124676726.USD","LU1989772923.USD","BK4534","LU0266013472.USD","IBB","LU0234572021.USD","BK4007","MEDI","LU0980610538.SGD","IE00BBT3K403.USD","LU1093756168.USD","TRUH","LU2361044949.HKD","SG9999015341.SGD","LU0238689110.USD","LU0432979614.USD","LU0868494617.USD","LU1035773651.USD","LU1585245621.USD","SG9999001176.USD","LU1061106388.HKD","BK4585","LU2125154935.USD","LU1066051225.USD","SG9999002224.SGD","LEGN","LU1084165304.USD","LU1057294990.SGD","LU1066051811.HKD","LU0265550359.USD","LU2491050071.SGD","LU1069347547.HKD","LU1934455194.USD","JDOC","LU0289739699.SGD","LU2324357040.USD","XLV","LU1571399168.USD","IE00BN8TJ469.HKD","SGXZ57979304.SGD","IE00BLSP4239.USD","BK4505","LU1923622614.USD","BK4533","SG9999015358.SGD","LU2125154778.USD","LU2361044865.SGD","SG9999014575.USD","LU0130517989.USD","LU1116320737.USD","LU0265550946.USD","IE00BFTCPJ56.SGD","LU0006306889.USD","SG9999014567.USD","LU0965509283.SGD","GDOC","IHE","LU1989771016.USD","IE00BSNM7G36.USD","LU0203347892.USD","LU1066051498.USD","LU2089984988.USD","LU0965509101.SGD","LU1934455277.USD","LU1037948541.HKD","BK4559","IE00BJJMRZ35.SGD","LU1261432733.SGD","LU2023250504.SGD","SG9999001440.SGD","IE000M9KFDE8.USD","LU2237957811.SGD","SGXZ23171101.USD","LU0130102774.USD","SG9999014542.SGD","LU2491050154.USD","LU1934455863.HKD","LU1116320901.HKD","LU0058720904.USD","LU1917777945.USD","IE00B2B36J28.USD","LU0211331839.USD","LU2491049909.HKD","LU0098860793.USD","LU2357627491.SGD","LU2125909247.SGD","LU1023059063.AUD","VHT","LU0823416689.USD","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659902243","title":"Definium Therapeutics Price Target Raised to $66.00/Share from $50.00 by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2659902243","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659902243?lang=en_us&edition=fundamental","pubTime":"2026-08-13 03:25","pubTimestamp":1786562700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659092299","title":"U.S. Stocks on the MOVE-Sutro Biopharma, Humacyte","url":"https://stock-news.laohu8.com/highlight/detail?id=2659092299","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659092299?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:17","pubTimestamp":1786551433,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Sutro Biopharma, HumacyteAugust 12 (Reuters)-Wall Street's main indexes rose on Wednesday, with the Nasdaq outperforming peers as upbeat earnings from AI infrastructure fi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL6N4490YK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","SLNCF","CIEN","OPLN","HRB","SVV","ANNX","SMCI","OFAL","ABSI","CRWV","NCMI","UFO","WXM","LUMA","TAN","LAZR","UAMY","EGGY","EAT","ALT","TECH","NBIS","SMCL","SLXN","LQDA","SMMT","TRMB","O","DPRE","SLN","HUMA","BETA","CAVA","FSLR","STRO","EROC","SMWB","NBIZ","LOCL","CHTR","LITE","GAP","NBIX","CORD","DFTX","NTHI","PFGC","TPL","TSHA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}